Entrada Therapeutics Inc (TRDA)
16.45
+0.68
(+4.31%)
USD |
NASDAQ |
Sep 27, 16:00
16.47
+0.02
(+0.12%)
After-Hours: 20:00
Entrada Therapeutics Accounts Payable (Quarterly): 1.635M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.635M |
| March 31, 2024 | 2.527M |
| December 31, 2023 | 3.277M |
| September 30, 2023 | 0.752M |
| June 30, 2023 | 2.422M |
| March 31, 2023 | 6.474M |
| December 31, 2022 | 5.99M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.341M |
| June 30, 2022 | 4.622M |
| March 31, 2022 | 2.931M |
| December 31, 2021 | 0.706M |
| September 30, 2021 | 2.278M |
| June 30, 2021 | 1.881M |
| December 31, 2020 | 1.602M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.706M
Minimum
Dec 2021
6.474M
Maximum
Mar 2023
2.746M
Average
2.35M
Median
Accounts Payable (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 3.584M |
| Pfizer Inc | 5.106B |
| Sarepta Therapeutics Inc | 107.42M |
| Catalyst Pharmaceuticals Inc | 7.116M |
| Insmed Inc | 51.36M |